Polyclonal Antibodies
Anti-CAD Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P27708
Item Number : CM0029335
Price varies based on specs and customizations
- Application
- WB, IHC-P, IF/ICC, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 243kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | CAD Rabbit pAb |
| Remarks/Alias | CDG1Z; DEE50; GATD4; EIEE50; CAD |
| Species | Human |
| GeneID (Human) | 790 |
| GeneID | 790 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1650-1900 of human CAD (NP_004332.2) |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, IHC-P, IF/ICC, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | P27708 |
| Protein Weight | 243kDa |
| Shipping | Ice bag |
Biological Background: CAD Function and Localization
- CAD is a multifunctional protein that carries out the first three enzymatic activities of the de novo pyrimidine biosynthesis pathway: carbamoylphosphate synthetase (CPSase), aspartate transcarbamylase (ATCase), and dihydroorotase (DHOase).
- The CPSase function occurs in two steps: a glutamine-dependent amidotransferase (GATase) domain generates ammonia, which is then used by the ammonium-dependent carbamoyl phosphate synthetase domain to produce carbamoyl phosphate from ATP and hydrogencarbonate.
- ATCase catalyzes the formation of carbamoyl-L-aspartate from L-aspartate and carbamoyl phosphate.
- DHOase catalyzes the cyclization of carbamoyl aspartate to dihydroorotate, completing the initial steps of UMP synthesis.
- CAD localizes to both the cytoplasm and the nucleus.
- It is subject to acetylation and phosphorylation, and functions as a zinc- and metal-dependent allosteric enzyme.
- Mutations in CAD are associated with congenital disorder of glycosylation type 1Z (CDG1Z) and developmental and epileptic encephalopathy 50 (DEE50/EIEE50).
- Alternative names for CAD include Carbamoyl phosphate synthetase 2-aspartate transcarbamylase-dihydroorotase.
Experimental Guidance and Technical Tips
- The immunogen corresponds to a C-terminal region (aa 1650-1900) of human CAD; consider this when interpreting data in truncation or isoform studies.
- For western blotting, expect a band at approximately 243 kDa; use appropriate gel percentage and transfer conditions for high-molecular-weight proteins.
- In IHC-P and IF/ICC, both cytoplasmic and nuclear staining may be observed; include appropriate controls and optimize fixation/permeabilization.
- Validate the antibody in your specific sample type and application by running a dilution series, as optimal working concentrations can vary.
- Cross-reactivity with mouse and rat is reported; confirm performance in these species if they are part of your experimental system.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio provides diagnostic manufacturers, laboratories, and research institutes with one-stop access to IVD raw materials, technical services, and consulting—covering every stage from concept to clinic. This anti-CAD polyclonal antibody is a reliable reagent for studying pyrimidine metabolism, metabolic disorders, and associated epilepsy or glycosylation defects. Beyond this product, we offer validated antibody pairs, optimized monoclonal/polyclonal antibodies, bulk ancillary reagents, and sourcing support for rare targets to accelerate your diagnostic development.
Product Datasheet
Anti-CAD Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P27708
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!